The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience
Open accessAbstract
Background: Coeliac disease may be regarded as refractory disease (RCD) when symptoms persist or recur despite strict adherence to a gluten-free diet. RCD may be subdivided into types I and II with a phenotypically normal and aberrant intraepithelial T-cell population, respectively. RCD I seems to respond well to azathioprine/prednisone therapy. RCD II is usually resistant to any known therapy and transition into enteropathy-associated T-cell lymphoma (EATL) is common. Aim: To provide further insight into RCD and the development of EATL, by reporting on long-term survival and risk of transition of RCD into EATL in a large cohort of patients with complicated coeliac disease. Design and Methods: Retrospective comparison of responses to therapy in four groups of patients with complicated coeliac disease: 43, RCD I; 50, RCD II (total), of whom 26 with RCD II developed EATL after a period of refractoriness to a gluten-free diet (secondary EATL) and 13 were EATL patients without preceding history of complicated coeliac disease (de novo EATL). Results: No coeliac-disease-related mortality was recognised in the RCD I group. The overall 5-year survival in the RCD I group it was 96%; in the RCD II (total) group was 58%; and in the RCD II group after developing EATL it was only 8%. The 2-year survival in the de novo EATL group was 20% versus 15% in secondary EATL group (p = 0.63). Twenty-eight (56%) of the 50 patients with RCD II died, 23 (46%) due to EATL, 4 due to a progressive refractory state with emaciation and 1 from neurocoeliac disease. Conclusion: Remarkably, no patient with RCD I developed RCD II or EATL within the mean follow-up period of 5 years (range 2–15 years). A total of 52% of the RCD II patients developed EATL within 4–6 years after the diagnosis of RCD II. More aggressive and targeted therapies seem necessary in RCD II and EATL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma
Cellier, C., Delabesse, E., Helmer, C., Patey, N., Matuchansky, C., Jabri, B., Macintyre, E., Cerf-Bensussan, N., & Brousse, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02481-8 · Cited by 757
Mortality in patients with coeliac disease and their relatives: a cohort study
Corrao, G., Corazza, G. R., Bagnardi, V., Brusco, G., Ciacci, C., Cottone, M., Guidetti, C. S., Usai, P., Cesari, P., Pelli, M. A., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05554-4 · Cited by 591
COELIAC DISEASE AND MALIGNANCY
Swinson, C., Coles, E. C., Slavin, G., & Booth, C. C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91754-3 · Cited by 435
Abnormal intestinal intraepithelial lymphocytes in refractory sprue
Cellier, C., Patey, N., Mauvieux, L., Jabri, B., Delabesse, E., Cervoni, J., Burtin, M., Guy–Grand, D., Bouhnik, Y., Modigliani, R., et al. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70530-x · Cited by 403
Association of celiac disease and intestinal lymphomas and other cancers
Catassi, C., Bearzi, I., & Holmes, G. K. T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.027 · Cited by 370
Bagdi, E., Diss, T. C., Munson, P., & Isaacson, P. G. (1999) · Blood · doi:10.1182/blood.v94.1.260.413k40_260_264 · Cited by 294
Daum, S., Cellier, C., & Mulder, C. J. J. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.001 · Cited by 266
Self-citationAl–Toma, A., Goerres, M. S., Meijer, J. W. R., Peña, A. S., Crusius, J. B. A., & Mulder, C. J. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.011 · Cited by 217
Self-citationAzathioprine and prednisone combination therapy in refractory coeliac disease
Goerres, M. S., Meijer, J. W. R., Wahab, P. J., Kerckhaert, J. A. M., Groenen, P. J. T. A., Van Krieken, J. H. J. M., & Mulder, C. J. J. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01687.x · Cited by 193
Self-citationDistinction between coeliac disease and refractory sprue: a simple immunohistochemical method
Patey‐Mariaud de Serre, N., Cellier, C., Jabri, B., Delabesse, E., Verkarre, V, Roche, B., Lavergne, A., Brière, J., Mauvieux, L., Leborgne, M., et al. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.00926.x · Cited by 160
management of patients with non‐responsive coeliac disease
O'MAHONY, S., HOWDLE, P. D., & LOSOWSKY, M. S. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1996.66237000.x · Cited by 159
Daum, S., Weiss, D., Hummel, M., Ullrich, R., Heise, W., Stein, H., Riecken, E. O., & Foss, H. D. (2001) · Gut · doi:10.1136/gut.49.6.804 · Cited by 150
Are Complicated Forms of Celiac Disease Cryptic T-Cell Lymphomas?
Carbonnel, F., Grollet-Bioul, L., Brouet, J., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3879 · Cited by 147
Gluten‐Free Diet: The Medical and Nutrition Management of Celiac Disease
See, J. A., & Murray, J. A. (2006) · Nutrition in Clinical Practice · doi:10.1177/011542650602100101 · Cited by 135
Hadithi, M., Mallant, M., Oudejans, J. J., van Waesberghe, J. T. M., Mulder, C. J. J., & Comans, E. F. I. (2006) · PubMed · Cited by 117
Self-citationCongia, M., Cucca, F., Frau, F., Lampis, R., Melis, L., Clemente, M. G., Cao, A., & Virgiliis, S. D. (1994) · Human Immunology · doi:10.1016/0198-8859(94)90059-0 · Cited by 92
Cyclosporin in the treatment of adults with refractory coeliac disease—an open pilot study
Wahab, Crusius, Meijer, et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00718.x · Cited by 85
Coeliac Disease: Changing Views on Gluten-Sensitive Enteropathy
Wahab, P. J., Meijer, J. W. R., Goerres, M. S., & Mulder, C. J. J. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320621472 · Cited by 82
Self-citationHLA-DQA1 and HLA-DQB1 Genetic Markers and Clinical Presentation in Celiac Disease
Zubillaga, P., Vidales, M. C., Zubillaga, I., Ormaechea, V., García‐Urkía, N., & Vitoria, J. C. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200205000-00014 · Cited by 79
Defining gluten refractory enteropathy
Biagi, F., & Corazza, G. R. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200105000-00016 · Cited by 79
Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism
Carrington, M. N., Miller, T., White, M. B., Gerrard, B., Stewart, C., Dean, M. C., & Mann, D. L. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90073-v · Cited by 76
A Milligram of Gluten a Day Keeps the Mucosal Recovery Away: A Case Report
Biagi, F., Campanella, J., Martucci, S., Pezzimenti, D., Ciclitira, P. J., Ellis, H. J., & Corazza, G. R. (2004) · Nutrition Reviews · doi:10.1111/j.1753-4887.2004.tb00062.x · Cited by 61
Daum, S., Hummel, M., Weiss, D., et al. (2000) · Digestion · doi:10.1159/000007779 · Cited by 44
Intestinal lymphoma and enteropathy
Isaacson, P. G. (1995) · The Journal of Pathology · doi:10.1002/path.1711770202 · Cited by 31
Mauriño, E. C., Niveloni, S. I., Cherñavsky, A. C., Sugai, E., Vázquez, H., Pedreira, S. C., Períolo, N., Mazure, R. M., Smecuol, E., Moreno, M. D. L., et al. (2006) · PubMed · Cited by 24
Cited by
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.79 · Cited by 1,681
Celiac disease: Prevalence, diagnosis, pathogenesis and treatment
Gujral, N. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i42.6036 · Cited by 690
Celiac Disease: From Pathogenesis to Novel Therapies
Schuppan, D., Junker, Y., & Barisani, D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.008 · Cited by 606
Di Sabatino, A., & Corazza, G. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60254-3 · Cited by 555
Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II
Malamut, G., Afchain, P., Verkarre, V., Lecomte, T., Amiot, A., Damotte, D., Bouhnik, Y., Colombel, J., Delchier, J., Allez, M., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.069 · Cited by 382
Metadata
- Authors
- Al-toma, A., Verbeek, W. H. M., Hadithi, M., von Blomberg, B. M. E., & Mulder, C. J. J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2007-04-30
- Volume
- 56
- Issue
- 10
- Pages
- 1373-1378
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2113669472
- Cited by
- 339
- References
- 26
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.